Kimberly McGregor - Concepedia

Author

Kimberly McGregor

Foundation Medicine (United States)ORCID

Also Known As

Blais, Edik M., K McGregor, K. A. McGregor, K. McGregor, Kimberly Anne McGregor, Kimberly A. McGregor, Kimberly McGregor, McGregor K

123

Publications

960

Citations

H-Index

Concepts

All Affiliations

Foundation Medicine (United States)SUNY Upstate Medical University Wake Forest University University Hospital Heidelberg Heidelberg University

About

Kimberly McGregor is an author at Foundation Medicine (United States) specializing in pathology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	122
2	Pathology	4	4	122
3	Hepatology	1	1	10
4	Immunology	1	1	10
5	Molecular Medicine	1	1	10

Kimberly McGregor

Publications

826

Citations

H-Index

Page 1

	Year	Citations
Homologous Recombination Deficiency: Concepts, Definitions, and Assays Mark Stewart, Diana Merino Vega, Rebecca C. Arend, The Oncologist	2022	207
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix Honglin Jiang, Robert J. Torphy, Katja Steiger, Journal of Clinical Investigation	2020	130
A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer Ignacio Garrido‐Laguna, Kimberly McGregor, Mark Wade, Investigational New Drugs Phase I/ii StudyMedicinePharmacologyPathologyColorectal Cancer	2013	64
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer Abirami Sivapiragasam, Prashanth Ashok Kumar, Ethan Sokol, Cancer Medicine	2020	54
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker Kristen Kelley, Kenneth Grossman, Mary Brittain-Blankenship, BMC Cancer	2021	46
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns Mason A. Israel, Natalie Danziger, Kimberly McGregor, The Oncologist	2021	46
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer Smruthy Sivakumar, Dexter X. Jin, Hanna Tukachinsky, Nature Communications	2022	40
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer Glynn Weldon Gilcrease, David D. Stenehjem, Mark Wade, Investigational New Drugs First–line TreatmentOncologyGastrointestinal OncologyPhase I/ii StudyMedicine	2018	35
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing Nadine Tung, Kali Chatham Dougherty, Emily Stern Gatof, npj Precision Oncology	2023	33
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases Richard S.P. Huang, James Haberberger, Kimberly McGregor, The Oncologist	2021	30

Page 1